US5585104A
(en)
*
|
1995-04-12 |
1996-12-17 |
The Procter & Gamble Company |
Cleansing emulsions
|
US5827822A
(en)
*
|
1996-03-25 |
1998-10-27 |
Sangstat Medical Corporation |
Cyclosporin a formulations as nanoparticles
|
US5858401A
(en)
|
1996-01-22 |
1999-01-12 |
Sidmak Laboratories, Inc. |
Pharmaceutical composition for cyclosporines
|
JPH10218760A
(ja)
*
|
1997-02-04 |
1998-08-18 |
Nobel Igaku Kenkyusho:Kk |
ドライアイ治療用の微量油添加目薬
|
US5981607A
(en)
*
|
1998-01-20 |
1999-11-09 |
Allergan |
Emulsion eye drop for alleviation of dry eye related symptoms in dry eye patients and/or contact lens wearers
|
US6217895B1
(en)
*
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
AUPQ228199A0
(en)
*
|
1999-08-18 |
1999-09-09 |
Sly, Anthony William |
Ophthalmic fluid
|
DE60010913T2
(de)
|
1999-10-15 |
2005-06-09 |
Sucampo Ag |
Bizyklische Verbindungen, Zusammenstellung und Verfahren zu ihrer Stabilisierung
|
US7270767B1
(en)
|
1999-10-18 |
2007-09-18 |
Foster-Miller, Inc. |
Environmentally friendly de-icer and anti-icer compositions
|
ES2206363T3
(es)
*
|
2000-04-07 |
2004-05-16 |
Laboratoire Medidom S.A. |
Formulaciones oftalmicas a base de ciclosporina, de acido hialuronico y de polisorbato.
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
ES2392636T3
(es)
|
2000-07-14 |
2012-12-12 |
Allergan, Inc. |
Composiciones que contienen componentes terapéuticamente activos que tienen solubilidad mejorada
|
US7112588B2
(en)
|
2001-05-21 |
2006-09-26 |
Alcon, Inc. |
Use of proteasome inhibitors to treat dry eye disorders
|
US6872382B1
(en)
|
2001-05-21 |
2005-03-29 |
Alcon, Inc. |
Use of selective PDE IV inhibitors to treat dry eye disorders
|
ES2278049T3
(es)
|
2001-05-21 |
2007-08-01 |
Alcon, Inc. |
Uso de inhibidores de proteasoma para tratar trastornos de ojo seco.
|
WO2002095704A1
(en)
|
2001-05-21 |
2002-11-28 |
Alcon, Inc. |
Use of nf-kappa-b inhibitors to treat dry eye disorders
|
US6645994B1
(en)
|
2001-06-01 |
2003-11-11 |
Alcon, Inc. |
Method of treating dry eye disorders
|
US6872705B2
(en)
*
|
2001-07-13 |
2005-03-29 |
Allergan, Inc. |
Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
|
NZ531946A
(en)
*
|
2001-10-19 |
2005-09-30 |
Isotechnika Inc |
Preconcentrate formulations comprising cyclosporin analogue microemulsions that reduce adverse effects while maintaining high bioavailability
|
US6656460B2
(en)
|
2001-11-01 |
2003-12-02 |
Yissum Research Development |
Method and composition for dry eye treatment
|
US9216183B2
(en)
|
2002-02-04 |
2015-12-22 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US8758733B2
(en)
|
2002-02-04 |
2014-06-24 |
Allergan, Inc. |
Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists
|
US7351404B2
(en)
|
2002-02-04 |
2008-04-01 |
Allergan, Inc. |
Method of enhancing hair growth
|
US6982079B2
(en)
*
|
2002-04-26 |
2006-01-03 |
Allergan, Inc. |
Compositions for treating hyperemia
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
US6635654B1
(en)
|
2003-01-09 |
2003-10-21 |
Allergan, Inc. |
Ophthalmic compositions containing loratadine
|
US6984628B2
(en)
|
2003-07-15 |
2006-01-10 |
Allergan, Inc. |
Ophthalmic compositions comprising trefoil factor family peptides
|
US20050059583A1
(en)
|
2003-09-15 |
2005-03-17 |
Allergan, Inc. |
Methods of providing therapeutic effects using cyclosporin components
|
US20060009522A1
(en)
|
2004-07-01 |
2006-01-12 |
Reza Dana |
Compositions and methods for treating eye disorders and conditions
|
EP1765259B1
(en)
|
2004-07-01 |
2011-02-09 |
E-L Management Corp. |
Cosmetic compositions and methods for sensory cooling
|
US7151085B2
(en)
|
2004-11-15 |
2006-12-19 |
Allergan, Inc. |
Therapeutic methods using cyclosporine components
|
US7135455B2
(en)
*
|
2004-11-15 |
2006-11-14 |
Allergan, Inc |
Methods for the therapeutic use of cyclosporine components
|
US9241918B2
(en)
|
2005-03-16 |
2016-01-26 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
US7851504B2
(en)
|
2005-03-16 |
2010-12-14 |
Allergan, Inc. |
Enhanced bimatoprost ophthalmic solution
|
CN100478025C
(zh)
*
|
2005-03-25 |
2009-04-15 |
中国科学院上海药物研究所 |
一种环孢菌素a眼用微乳制剂及其制备方法
|
CN100562340C
(zh)
*
|
2005-06-17 |
2009-11-25 |
中国科学院上海药物研究所 |
一种微乳型人工泪液
|
CN1319515C
(zh)
*
|
2005-07-12 |
2007-06-06 |
沈阳何氏生物工程有限公司 |
活肤眼霜
|
US20070015691A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US7276476B2
(en)
|
2005-07-13 |
2007-10-02 |
Allergan, Inc. |
Cyclosporin compositions
|
US7297679B2
(en)
*
|
2005-07-13 |
2007-11-20 |
Allergan, Inc. |
Cyclosporin compositions
|
US7202209B2
(en)
*
|
2005-07-13 |
2007-04-10 |
Allergan, Inc. |
Cyclosporin compositions
|
US20070015693A1
(en)
*
|
2005-07-13 |
2007-01-18 |
Allergan, Inc. |
Cyclosporin compositions
|
US7288520B2
(en)
*
|
2005-07-13 |
2007-10-30 |
Allergan, Inc. |
Cyclosporin compositions
|
US8288348B2
(en)
*
|
2005-07-13 |
2012-10-16 |
Allergan, Inc. |
Cyclosporin compositions
|
US7501393B2
(en)
*
|
2005-07-27 |
2009-03-10 |
Allergan, Inc. |
Pharmaceutical compositions comprising cyclosporins
|
US7745400B2
(en)
*
|
2005-10-14 |
2010-06-29 |
Gregg Feinerman |
Prevention and treatment of ocular side effects with a cyclosporin
|
US9839667B2
(en)
|
2005-10-14 |
2017-12-12 |
Allergan, Inc. |
Prevention and treatment of ocular side effects with a cyclosporin
|
EP1956906A4
(en)
|
2005-11-09 |
2009-12-30 |
Combinatorx Inc |
METHODS, COMPOSITIONS AND KITS FOR THE TREATMENT OF PATHOLOGIES
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
US9561178B2
(en)
*
|
2006-07-25 |
2017-02-07 |
Allergan, Inc. |
Cyclosporin compositions
|
US10265265B2
(en)
|
2007-03-15 |
2019-04-23 |
Drug Delivery Solutions Limited |
Topical composition
|
EP2152291B1
(en)
*
|
2007-05-04 |
2012-10-24 |
Allergan, Inc. |
Use of cyclosporines in the treatment of patients with intraocular lenses
|
FR2916636B1
(fr)
*
|
2007-05-29 |
2009-09-04 |
Octalia Technologies |
Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation ophtalmique ou dermocosmetique
|
EP2008651A1
(en)
|
2007-06-26 |
2008-12-31 |
Drug Delivery Solutions Limited |
A bioerodible patch
|
WO2009048929A1
(en)
|
2007-10-08 |
2009-04-16 |
Lux Biosciences, Inc. |
Ophthalmic compositions comprising calcineurin inhibitors or mtor inhibitors
|
KR100985279B1
(ko)
*
|
2008-03-05 |
2010-11-05 |
디렉스 팜 (주) |
안구건조증 치료를 위한 안약조성물 및 그 제조방법
|
CN102149402B
(zh)
*
|
2008-07-10 |
2014-07-09 |
阿勒根公司 |
用于治疗眼睛和皮肤的疾病和病症的环孢菌素衍生物
|
US20100016219A1
(en)
*
|
2008-07-19 |
2010-01-21 |
Jerry Zhang |
Ophthalmic compositions containing solubilized cyclosporin
|
FR2938757B1
(fr)
*
|
2008-11-27 |
2010-12-31 |
Octalia Technologies |
Vehicule sous forme d'une emulsion huile-dans-eau notamment destine a une utilisation cosmetique ou dermatologique
|
US20100204335A1
(en)
*
|
2008-12-01 |
2010-08-12 |
Allergan, Inc. |
Kit and composition for eyelash growth
|
WO2010080913A1
(en)
*
|
2009-01-08 |
2010-07-15 |
Allergan, Inc. |
Cyclosporine compositions for enhancing nail growth
|
US20110009339A1
(en)
|
2009-04-14 |
2011-01-13 |
Allergan, Inc |
Method of treating blurred vision and other conditions of the eye with cyclosporin compositions
|
WO2010127301A1
(en)
*
|
2009-05-01 |
2010-11-04 |
Allergan, Inc. |
Method of treating allergic conjunctivitis with cyclosporin compositions
|
MX358504B
(es)
|
2009-06-05 |
2018-08-21 |
Allergan Inc |
Lagrimas artificiales y usos terapeuticos.
|
CN102458370A
(zh)
|
2009-06-09 |
2012-05-16 |
卢克斯生物科技公司 |
用于眼科用途的表面药物递送***
|
US9149484B2
(en)
|
2009-11-09 |
2015-10-06 |
Allergan, Inc. |
Compositions and methods for stimulating hair growth
|
KR101769637B1
(ko)
|
2009-11-09 |
2017-08-18 |
알러간, 인코포레이티드 |
모발 성장을 촉진하기 위한 조성물 및 방법
|
US9522153B2
(en)
|
2009-12-22 |
2016-12-20 |
Allergan, Inc. |
Compositions and methods for lowering intraocular pressure
|
CN101897949B
(zh)
*
|
2010-02-24 |
2016-07-06 |
温士顿医药股份有限公司 |
低刺激性透明乳化液剂型以供眼睛或眼睛周围有关组织表面免疫调节及消炎的眼用药物组合物
|
US20110294744A1
(en)
*
|
2010-05-25 |
2011-12-01 |
Allergan, Inc. |
Cyclosporin emulsions
|
WO2012015211A2
(ko)
*
|
2010-07-30 |
2012-02-02 |
주식회사종근당 |
사이클로스포린 에이 함유 점안제 조성물
|
US8492557B2
(en)
|
2010-09-16 |
2013-07-23 |
Allergan, Inc. |
Ester pro-drugs of [3-(1-(1H-imidazol-4-yl)ethyl)-2-methylphenyl] methanol
|
WO2012051193A1
(en)
|
2010-10-12 |
2012-04-19 |
Allergan, Inc. |
Cyclosporin analogs
|
BR112013008864A2
(pt)
|
2010-10-12 |
2016-06-28 |
Allergan Inc |
análogos d ciclosporina
|
CA2818610C
(en)
|
2010-11-18 |
2020-02-18 |
Steven Yoelin |
Compositions and methods for hair growth
|
US9018202B2
(en)
|
2010-12-03 |
2015-04-28 |
Allergan, Inc. |
Methods for treating diseases of the retina
|
EP2659903B1
(en)
*
|
2010-12-28 |
2016-09-14 |
Hanlim Pharmaceutical Co., Ltd. |
Nanoemulsion-type ophthalmic composition
|
US8859616B2
(en)
|
2011-01-21 |
2014-10-14 |
Allergan, Inc. |
Compounds and methods for enhancing hair growth
|
MX344046B
(es)
|
2011-01-26 |
2016-12-02 |
Allergan Inc |
Composicion de androgeno para tratar una afeccion oftalmica.
|
JP6105494B2
(ja)
*
|
2011-03-14 |
2017-03-29 |
ドラッグ デリバリー ソリューションズ リミテッド |
眼科用組成物
|
KR102079402B1
(ko)
*
|
2011-05-27 |
2020-02-19 |
알러간, 인코포레이티드 |
사이클로스포린 a의 결정형, 이의 제조 방법 및 이의 사용 방법
|
KR20140054005A
(ko)
*
|
2011-06-29 |
2014-05-08 |
알러간, 인코포레이티드 |
마크로골 15 하이드록시스테아레이트 제형
|
US20130029919A1
(en)
|
2011-07-26 |
2013-01-31 |
Allergan, Inc. |
Two part formulation system for opthalmic delivery
|
DE102011108948A1
(de)
|
2011-07-29 |
2013-01-31 |
Achim Göpferich |
Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
|
CN103987370A
(zh)
|
2011-10-05 |
2014-08-13 |
阿勒根公司 |
用于增进指甲健康的组合物
|
BR112014008190A2
(pt)
*
|
2011-10-05 |
2017-04-18 |
Allergan Inc |
composições para realce da saúde da unha
|
US8957048B2
(en)
|
2011-10-06 |
2015-02-17 |
Allergan, Inc. |
Compositions for the treatment of dry eye
|
AU2012339632A1
(en)
|
2011-11-15 |
2014-06-05 |
Allergan, Inc. |
Suspensions of cyclosporin A Form 2
|
AU2012339701B8
(en)
*
|
2011-11-15 |
2017-11-16 |
Allergan, Inc. |
Autoclavable suspensions of cyclosporin A Form 2
|
EP2782569A1
(en)
|
2011-11-21 |
2014-10-01 |
Allergan, Inc. |
Pharmaceutical compositions comprising 4-[1-(2,3-dimethylphenyl)ethyl]-3h-imidazole derivatives for treating retinal diseases
|
US9907826B2
(en)
|
2011-12-07 |
2018-03-06 |
Allergan, Inc. |
Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
|
US20130197002A1
(en)
|
2012-01-30 |
2013-08-01 |
Allergan, Inc. |
Brimonidine for treating visual disorders mediated by central visual projections from the eye
|
US9278132B2
(en)
*
|
2012-02-13 |
2016-03-08 |
Bausch & Lomb Incorporated |
Ophthalmic pharmaceutical compositions and methods of making and using same
|
US20150164765A1
(en)
|
2012-05-17 |
2015-06-18 |
Steven G. Yoelin |
Compositions and methods for hair growth
|
EP2855508B1
(en)
|
2012-06-01 |
2018-02-14 |
Allergan, Inc. |
Cyclosporin a analogs
|
WO2014138437A1
(en)
|
2013-03-08 |
2014-09-12 |
Allergan, Inc. |
Steroid conjugates
|
KR101492447B1
(ko)
|
2013-05-20 |
2015-02-23 |
주식회사태준제약 |
사이클로스포린을 함유하는 나노에멀젼 점안 조성물 및 그의 제조 방법
|
BR112017001017A2
(pt)
*
|
2014-07-18 |
2018-01-23 |
Allergan Inc |
composições em suspensão de ciclosporina a para injeção subconjuntival e periocular
|
NZ732058A
(en)
|
2014-11-25 |
2023-06-30 |
Allergan Inc |
Stabilized omega-3 ophthalmic compositions
|
WO2016112321A1
(en)
|
2015-01-08 |
2016-07-14 |
Allergan, Inc. |
Cyclosporin derivatives wherein the mebmt sidechain has been cyclized
|
US20200237859A1
(en)
|
2019-01-25 |
2020-07-30 |
Newport Research, Inc. |
Aqueous suspensions of cyclosporin
|
US11324800B2
(en)
|
2015-01-15 |
2022-05-10 |
Wellspring Ophthalmics, Inc. |
Aqueous suspensions of cyclosporin
|
ES2922815T3
(es)
|
2015-02-06 |
2022-09-20 |
Woodstock Sterile Solutions Inc |
Preparación de una emulsión de aceite en agua para formulaciones farmacéuticas estabilizadas con polímeros
|
WO2016160362A1
(en)
|
2015-03-31 |
2016-10-06 |
Allergan, Inc. |
Cyclosporins modified on the mebmt sidechain by heterocyclic rings
|
KR101587385B1
(ko)
|
2015-07-29 |
2016-01-21 |
국제약품공업주식회사 |
사이클로스포린 함유 무자극성의 안약조성물 및 편리한 제조방법
|
US9820954B2
(en)
|
2015-08-19 |
2017-11-21 |
Jenivision Inc. |
Quantitative peri-orbital application of ophthalmology drugs
|
FR3041883B1
(fr)
*
|
2015-10-02 |
2019-03-15 |
Chu Clermont-Ferrand |
Procede de preparation d'un collyre de ciclosporine a
|
EP3362096B1
(en)
|
2015-10-14 |
2023-12-13 |
Paul Gavaris |
Ophthalmic treatment composition and vehicle for delivery of pharmaceutical substances or therapeutic agents
|
CN106692052B
(zh)
*
|
2015-11-13 |
2021-03-26 |
天津金耀集团有限公司 |
一种环孢素眼用乳剂组合物
|
CN109963556A
(zh)
*
|
2016-11-17 |
2019-07-02 |
千寿制药株式会社 |
乳剂滴眼液
|
KR102115158B1
(ko)
|
2016-11-29 |
2020-05-26 |
주식회사 지트리파마슈티컬 |
티모신 베타 4 를 함유하는 제형
|
US20190224275A1
(en)
|
2017-05-12 |
2019-07-25 |
Aurinia Pharmaceuticals Inc. |
Protocol for treatment of lupus nephritis
|
USD841152S1
(en)
|
2017-06-27 |
2019-02-19 |
Monica S. Naylor |
Eye drop container
|
EP3542788A1
(en)
|
2018-03-19 |
2019-09-25 |
MC2 Therapeutics Limited |
Topical composition comprising calcipotriol and betamethasone dipropionate
|
CN109010268B
(zh)
*
|
2018-09-28 |
2020-07-10 |
湖北远大天天明制药有限公司 |
一种提高氯霉素稳定性的眼用组合物及其制备方法
|
EP3982930A1
(en)
|
2019-06-11 |
2022-04-20 |
SIFI S.p.A. |
Microemulsion compositions
|
US20220378698A1
(en)
*
|
2019-07-12 |
2022-12-01 |
Pharmathen S.A. |
Preservative free pharmaceutical composition for ophthalmic administration containing cyclosporine
|
US20220288090A1
(en)
|
2019-08-07 |
2022-09-15 |
Aneira Pharma Inc. |
Methods And Compositions For The Treatment Of Hair Loss
|
GR1010012B
(el)
*
|
2020-05-12 |
2021-05-27 |
Φαρματεν Α.Β.Ε.Ε. |
Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον κυκλοσπορινη
|
CN113749092A
(zh)
*
|
2020-06-03 |
2021-12-07 |
迈克斯(如东)化工有限公司 |
不饱和脂肪酸酯化物应用、农化组合物和低眼刺农药制剂及其应用
|
IL294896A
(en)
*
|
2022-07-20 |
2024-02-01 |
LYOTROPIC DELIVERY SYSTEMS Ltd |
Topical administration of cyclosporine to the eye
|
WO2024150216A1
(en)
*
|
2023-01-09 |
2024-07-18 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Topical compositions and methods for treating alopecia
|